Table 1.
CNV category | Syndromic CHD cases a | Isolated CHD cases (n = 162) | Syndromic CHD vs. Isolated CHD p Value | |||
---|---|---|---|---|---|---|
Syndromic CHD cases with co-occurring DD/ID or ASD (n = 75) | Syndromic CHD cases without DD/ID and ASD(n = 173) | p Value | Total cases (n = 248) | |||
Non-polymorphic CNVs | 38 (50.7%) | 60 (34.7%) | 0.0234 | 98 (39.5%) | 43 (26.5%) | 0.0078 |
Pathogenic CNVs | 17 (22.7%) | 18 (10.4%) | 0.0163 | 35 (14.1%) | 7 (4.3%) | 0.0013 |
Pathogenic + likely pathogenic CNVs | 22 (29.3%) | 29 (16.7%) | 0.0275 | 51 (20.6%) | 15 (9.3%) | 0.0024 |
aTwelve patients with aneuploidy were not included.
The following abbreviations were used: DD, development delay; ID, intellectual disability; ASD, autism spectrum disorder.